Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glauconix Biosciences is a specialty contract research organization (CRO) that provides advanced 3D human tissue models for ophthalmic drug development. The company's proprietary platform mimics the fluid dynamics and physiological complexity of the human eye, specifically the trabecular meshwork, to help pharmaceutical companies screen and validate drug candidates. By providing more predictive data than traditional animal models, Glauconix accelerates the development of treatments for glaucoma and other ocular diseases. Their services include drug efficacy testing, toxicity screening, and mechanism of action studies using high-throughput microfluidic technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glauconix Biosciences.